Influencer Tanner Martin dead at 30 of colon cancer — this was his first symptom
Martin was diagnosed with the disease, which occurs when cells in the colon grow out of control, in 2020 at the age of 25.
While colon cancer is traditionally linked to older adults, diagnoses among younger people have skyrocketed in recent years.
4 Tanner Martin was diagnosed with colon cancer in 2020 at the age of 25.
The Washington Post via Getty Images
Oncologists have suggested that the concerning rise in youth cases and deaths could be due to obesity, a sedentary lifestyle, the Western diet, excess sugar consumption and environmental factors such as pollutants in the air, soil and water. The exact causes are still unclear.
Martin's first symptom was a mild but persistent stomachache that began in 2020. He said that the pain was not debilitating but made him feel unwell.
Gastrointestinal medical oncologist Benny Johnson notes that some 15% of colon cancer patients report abdominal pain, described as an 'intermittent crampy feeling.'
Martin then began experiencing severe constipation.
4 Though colorectal cancer can sometimes be asymptomatic, a change in bowel habits or caliber of stool — as well as rectal bleeding or weight loss — are among the most common symptoms.
M+Isolation+Photo – stock.adobe.com
Though colon cancer can sometimes be asymptomatic, a change in bowel habits or stool — as well as rectal bleeding or weight loss — are among the classic symptoms.
Experts maintain that constipation now and then isn't a cause for concern, but if you're normally regular — and then you're stopped up for weeks or months at a time — that's not normal and could be a sign that cancer is obstructing your bowels.
'If you notice persistent diarrhea, constipation or a change in the shape, size, consistency or frequency of your stool, don't simply brush it off as stress or diet changes,' Dr. Cedrek McFadden, a colorectal surgeon based in South Carolina and medical adviser to the Colorectal Cancer Alliance, previously told The Post.
Also watch for fatigue. A low red blood cell count, known as anemia, is present in 30% to 75% of colorectal cancer patients and can contribute to feelings of exhaustion.
Despite Martin's telltale symptoms, his initial bloodwork was normal, and it took six months for a specialist to recommend him for a colonoscopy.
4 Despite Martin's telltale symptoms, his bloodwork was normal, and it took six months for a specialist to recommend him for a colonoscopy.
Instagram / tannerandshay
Because of the rise in younger cases, the US Preventive Services Task Force updated its colorectal cancer screening guidelines in 2021 to lower the recommended age to start screening from 50 to 45 for adults at average risk.
By the time Martin underwent the procedure, doctors discovered that the cancer had spread from his colon to his liver. He was given a Stage 4 terminal diagnosis.
According to the Washington Post, young people like Martin, who are of Native American descent, have the highest rate of colorectal cancer of any racial and ethnic group.
Despite his grim prognosis, Martin finished college and found a job, but the fatigue from his treatments and the toll of five surgeries made it impossible for him to work.
He began documenting his cancer journey on TikTok and Instagram, where his candor and optimism made him a viral sensation.
4 In 2024, in light of what appeared to be an effective treatment, Martin and Shay decided to start a family.
The Washington Post via Getty Images
Martin and his wife, Shay, also started the nonprofit Rebels Against Cancer.
Martin, who had always dreamed of being a father, banked his sperm shortly after his diagnosis, as infertility is a common side effect of chemotherapy.
In 2024, in light of what appeared to be an effective treatment for Martin, he and Shay decided to start a family. However, by 2025, Martin's condition had taken a turn for the worse, spreading to his lymph nodes, and he was uncertain whether he would live long enough to meet his daughter.
He and Shay welcomed Amy Lou on May 15.
Martin announced his untimely passing in a prerecorded video shared by Shay on Wednesday.
He wanted to record a 'lighthearted' video ahead of his death so Shay could upload it and focus on grieving.
Martin, who did not have life insurance, also recorded a separate video in which he shared that his dying wish was for fans to donate to his widow and newborn daughter through a GoFundMe fundraiser, 'to help replace what I would be there for.'
'For less than the price of a hot and spicy McChicken (Tanner's words…LOL), you can give them a future Tanner only wished he could stay to provide,' the page said.
The fundraiser has raised over $500,000 so far.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
44 minutes ago
- Yahoo
Covid is rising. New vaccines may not be ready until mid-September.
Coronavirus infections are climbing again, marking another summer wave as children go back to school. But this uptick arrives with an added layer of uncertainty because it's unclear when and which Americans can receive updated vaccines this fall. Subscribe to The Post Most newsletter for the most important and interesting stories from The Washington Post. Daniel R. Kuritzkes, chief of the division of infectious diseases at Brigham and Women's Hospital in Boston, said the current rise looks similar to seasonal bumps in previous years and is not driving a surge in severe illness. This is the new rhythm of covid waves. Many people are getting sick - some feeling lousy - especially after returning from vacation and conferences. Most probably won't even know it's covid because the symptoms can be indistinguishable from a cold or other respiratory bug. Yet hospitals are no longer flooded with patients because immune systems are much better trained to fight the virus five years after it arrived. But Kuritzkes and other medical and public health experts worry that delays and confusion surrounding the vaccines will limit access for those who need them the most: Adults ages 65 and older and people who have chronic conditions, weakened immune systems or are pregnant. The federal committee that would recommend the updated coronavirus vaccine is not expected to meet until at least mid-September, according to industry employees and Centers for Disease Control and Prevention officials who spoke on the condition of anonymity to share sensitive information. By that point, the summer covid wave could be over, but Americans could still get a boost of immunity ahead of an expected winter wave. Here's what to know about the latest with covid and how to protect yourself: - - - What does the data show? Several metrics tracked by the CDC show a midsummer uptick of coronavirus underway in the United States. Viral levels in wastewater started rising in late June and are considered high in the West, South and Midwest and headed that direction in the Northeast, according to Marlene Wolfe, principal investigator and co-program director of WastewaterSCAN, a private initiative that tracks municipal sewage data. The levels of virus are roughly one-third of the levels recorded a year ago, when the country was experiencing an unusually large summer covid wave. Emergency room data suggests infections are disproportionately affecting children. As of Aug. 7, coronavirus diagnoses accounted for 2.18 percent of emergency room visits among children up to age 11, the largest jump of any age group. Still, some experts caution that numbers are still very small. Aaron Milstone, a pediatric infectious-disease specialist at Johns Hopkins University School of Medicine, said most children now have some level of hybrid immunity from prior infection and vaccination. But vaccines still play a key role in giving a child's body a robust immune response, he said. 'Parents get frustrated that they get their kids the vaccine and they still contract it, but the biggest point is that they didn't die or get severe illness,' said Milstone. 'It's like wearing a seat belt. It doesn't prevent an accident, but it decreases the likelihood of dying from one.' - - - What are the latest variants? Coronavirus is always evolving to become more transmissible or adept at overcoming the frontline immune defenses that stop infections. The current predominant variant is XFG, according to CDC wastewater tracking. XFG is an offshoot of the JN.1 subvariant of omicron that became dominant in the winter of 2023-2024. The Food and Drug Administration has advised vaccine manufacturers to update their formulas to target the JN.1 lineage, specifically using the LP.8.1 strain that was dominant in the spring and is closely related to XFG. The latest variants do not appear to cause worse symptoms or have significant differences compared with its predecessors, according to Scott Roberts, an assistant professor of infectious diseases at Yale School of Medicine. - - - What's the latest with vaccines? For the coming fall season, the FDA has not yet approved an updated coronavirus vaccine. In recent years, the agency has typically signed off on an updated version by late August or early September in order for pharmacies and doctors' offices to place orders. But the agency is expected to narrow its approval for the vaccine to those 65 and older, as well as others considered at high risk for severe disease. The new approach marks a significant shift from past years when the shots have been broadly available, including to children and generally healthy adults. Once the FDA gives the greenlight, the CDC's Advisory Committee on Immunization Practices decides who should get the shots. Most insurers must pay for ACIP-recommended vaccines. Most of the newly appointed members of that committee have been critical of U.S. coronavirus vaccine policy. It's unclear whether Americans who are not considered high risk could still pay out-of-pocket to get a coronavirus vaccine off-label. That depends on the willingness of - and legal restrictions on - health care providers who would administer shots. Most Americans have at least one condition that puts them at higher risk of severe illness from covid. Physical inactivity, asthma, obesity, smoking and mood disorders are among the widespread risk factors highlighted under the new FDA framework for coronavirus vaccine approval. AHIP, the major insurance lobby, has said its members are committed to maintaining coverage of vaccines for the upcoming respiratory virus season. The FDA may not sign off on Pfizer's updated coronavirus vaccine for children between the ages of six months and 4, the company said in a statement, adding the change has nothing to do with the safety and efficacy of the shot. However, the agency recently granted full approval to Moderna's shot for young kids at risk of severe disease. The CDC stopped offering specific coronavirus vaccine guidance to pregnant women. The American College of Obstetricians and Gynecologists has strongly criticized that move, noting research has shown the virus can be dangerous for expecting mothers and cause birth complications. - - - How can I protect myself and others? Public health experts say the best way to protect yourself from covid is to stay up-to-date on vaccines. The 2024-2025 vaccine formula is still available. But it might be harder to find because some doctors and pharmacies may have decided not to restock their supplies while they wait for a new version to arrive. The CDC recommends two doses of the vaccine for people who are 65 and older or are immunocompromised. Jessica Justman, an infectious disease specialist at Columbia University, said if someone in those groups had not yet received their second dose, they should go ahead and get it now, especially if they anticipate increased exposure such as attending a large indoor gathering. The primary purpose of vaccination is to reduce the risk of severe disease, hospitalization and death. For those wanting to avoid infections completely, experts advise wearing surgical or KN95/N95 masks, avoiding crowded indoor settings and ventilating rooms. For those who get infected, the CDC guidance to resume normal activities is to wait until your symptoms are improving and you have been fever-free for 24 hours without using fever-reducing medication. Then you should take precautions for an additional five days, such as social distancing and masking. - - - Rachel Roubein and Lena H. Sun contributed to this report Related Content Ukraine scrambles to roll back Russian eastern advance as summit takes place Her dogs kept dying, and she got cancer. Then they tested her water. D.C.'s homeless begin to see the effects of Trump's crackdown Solve the daily Crossword
Epoch Times
5 hours ago
- Epoch Times
FDA Advises Americans Against ‘Mousse' Sunscreens, Warns 5 Manufacturers
Americans should 'beware' of sunscreen products in mousse form as they may not be effective, the Food and Drug Administration (FDA) said in an Aug. 12 X post, with the agency sending warning letters to five companies marketing sunscreen products. The letters were sent on Aug. 6 to Texas-based Supergoop, Pennsylvania-based Fallien Cosmeceuticals Ltd., Israel-based K & Care Organics, Sweden-based Kalani AB, and Florida-based Vacation Inc.
Los Angeles Times
8 hours ago
- Los Angeles Times
Unlocking Cellular Health With Science and Trust
In the longevity and wellness space, Niagen Bioscience is charting a course defined by both scientific rigor and an unwavering commitment to responsible innovation Niagen Bioscience (NASDAQ: NAGE, formerly Chromadex) is a Los Angeles-based company dedicated to advancing the supplements industry using science-backed research into their component ingredients. At the helm is CEO Robert Fried, who says the company's mission is to pioneer NAD+ research and develop transformative NAD-boosting healthy-aging solutions with Niagen, their patented form of nicotinamide riboside (NR). Niagen is the cornerstone of the company's clinically proven product portfolio, Tru Niagen and Niagen IV and injections. During this year's Cannes Lions, Fried sat down with LA Times Studios to discuss how the company is pioneering the NAD+ space and the science and quality backed benefits of its Niagen products. 'NAD+, or nicotinamide adenine dinucleotide, is a co-enzyme found in all living cells – plant and animal – and is involved in all important metabolic processes within the cell, but especially energy metabolism and DNA repair, which are key to supporting mitochondrial health and overall optimal health.' explained Fried. Mitochondria, the 'battery pack of the cell,' combines nutrients from the food you eat and oxygen with NAD+ to produce energy. NAD+ also plays a crucial role in DNA recovery and cellular repair. 'All of these processes that exist within the cell where the cell repairs damage are NAD+ dependent,' Fried emphasized, illustrating how higher NAD+ levels facilitate rapid healing, contrasting youthful recovery with a slower healing process that occurs as we age. This is because NAD+ starts to decline naturally in our 30s, with research showing a dramatic drop of up to 65% by the time we reach age 70. Exposure to stressors like sedentary lifestyle, excess sun exposure, poor diet and environmental factors also impact NAD+ levels. Research shows that NAD+ decline is associated with a decline in overall health and vitality, contributing to the development of conditions and disease. Fried is quick to address a significant industry misconception: 'NAD+ itself is not bioavailable. If you consume NAD+ orally or with an IV, it will not elevate NAD+ levels inside your cells.' He clarified that the NAD+ molecule is too large to penetrate cells, causing NAD+ supplements and IV to be ineffective. Intact NAD+ may even have the potential to cause acute immune inflammatory response, which may be responsible for the uncomfortable side effects associated with NAD+ IV and injections. The solution, according to Fried, is 'to consume an NAD+ precursor molecule that easily gets into the cell and then converts into NAD+, and the best molecule for this is called nicotinamide riboside or NR.' Niagen is patented NR and precisely what Tru Niagen and pharmaceutical-grade Niagen IV and injections offer. With a legacy spanning over 25 years, the company's recent rebranding from ChromaDex to Niagen Bioscience reflects its sharpened focus. 'We're no longer only a reference standards company but an NAD+ company dedicated to addressing one of life's most complex challenges - aging,' said Fried. Niagen Bioscience differentiates itself by operating as an 'R&D lab that specializes in NAD+,' not simply a supplement distributor, he said. Its distinguished by state-of-the-art laboratories, rigorous scientific and quality protocols, and an external research program helping independent investigators and institutions worldwide uncover the potential of NAD+. 'There is no other company in the supplement space that comes close this level of R&D investment and scientific research,' Fried asserted. The company boasts 38 peer-reviewed, published human clinical studies on oral food-grade Niagen, of which about 95% are completely independent, with another 40 studies currently underway. This level of scientific rigor, he contends, is typically found only in biotech or pharmaceutical companies. Products are tested at the manufacturing facility and then retested upon delivery. Fried notes their marketing: 'We are real. We are genuine. We let the science do the talking.' This approach, he believes, is key to building genuine trust. Niagen Bioscience is exploring Niagen's broader therapeutic potential for its patented NR. Fried reveals extensive clinical studies on the benefits of its patented food-grade NR for specific age-related and orphan diseases (rare conditions characterized by rapid aging). Some of these studies have reached Phase II and III clinical trials. A 52 week, 400-participant, Phase III double-blinded, controlled study on Parkinson's disease recently concluded, conducted with a world-renowned independent researcher. 'That is a level of scientific research ... that you don't see from supplement companies,' Fried emphasized. Niagen Bioscience is also innovating beyond oral supplements. They've developed a pharmaceutical-grade version of nicotinamide riboside, now available as Niagen IV. exclusively at clinics across the U.S. Fried highlighted its advantages: 'If you do an injection or an IV, you're getting the benefits of Niagen directly to the bloodstream.' This results in faster absorption and avoids side effects often associated with direct NAD+ infusions. Fried candidly addresses his concern about a lack of public trust in the dietary supplement industry, citing prevalent unsubstantiated claims, low-quality products, and marketing hype. 'It's my belief that if people genuinely trusted the companies that the industry at large would be so significant because we'd actually have preventative health value,' he states. To combat this, Niagen Bioscience has proposed a 'Trust Alliance' – a coalition of industry players, government and non-profits to test products and ensure claims are met. For Fried, the most meaningful aspect of his journey is receiving letters from individuals who experienced health benefits after taking Tru Niagen. Looking ahead, Niagen Bioscience aims to solidify its position as the 'gold standard in the NAD+ space,' continuing its scientific leadership. 'Our mission is to help every living being around the world age better. We think what could happen in the next five years is very exciting and special,' Fried concluded.
